The initial findings from the enzyme-linked immunosorbent assay (ELISA) indicated a statistically significant downregulation of pyroptosis protein expression in melanoma patients when compared to the control group (Fig. 2C), especially NLRP1, GZMA, and GSDMB, followed by CHMP4A and IL18. This evidence concerns the gene NLRP1 and melanoma.